LFWD
Lifeward Ltd.NASDAQHealthcare$6.86+0.88%ClosedMarket Cap: $10.5M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.21
P/S
0.47
EV/EBITDA
-0.60
DCF Value
$-276.92
FCF Yield
-161.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
38.3%
Operating Margin
-76.7%
Net Margin
-90.4%
ROE
-145.5%
ROA
-87.0%
ROIC
-149.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $5.1M | $-5.3M | $-3.60 |
| FY 2025 | $22.0M | $-19.9M | $-17.16 |
| Q3 2025 | $6.2M | $-3.2M | $-2.40 |
| Q2 2025 | $5.7M | $-6.6M | $-6.96 |
Analyst Ratings
View AllHC Wainwright & Co.Buy
2026-03-19HC Wainwright & Co.Buy
2025-11-18Trading Activity
Insider Trades
View AllAdar Almogofficer: Chief Financial Officer
SellFri Mar 27
Kidron Miriamdirector:
SellFri Mar 27
KIDRON NADAVdirector:
SellFri Mar 27
Reznick Yehudadirector:
SellFri Mar 27
Kidron Miriamdirector
SellFri Mar 27
Company Info
Sector
Healthcare
Industry
—
Country
IL
Exchange
NASDAQ
Beta
0.16
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.